# Cirrhosis and Stroke data 
---
## Cirrhosis Data Set 
### Brief Decscription of Data 

Data Source: https://www.kaggle.com/datasets/fedesoriano/cirrhosis-prediction-dataset

Total of 424 PBC patients that was referred by ther Mayo clinic during a ten-year interval had met an eligible criteria for a randomized placebo-control trial of the drug D-penicillamine. For the first 312 patients that participated in this clinical trial. However, 112 patients did not participate in the clinical trial, but consented to have the basic measurements recorded and siz of the cases were lost to follow-up shortly after diagnosis. 

#### Target: Drug - the type of drug that was given to the patients during the clinical trial (placebo or D-penicillamine).
#### Number of Features: 19 Features in this dataset. 
---
## Visual One:
![image](https://user-images.githubusercontent.com/122195358/231598053-eb90a4df-e1fe-4b18-9ba5-dcc76bb7c0b8.png)
#### The visual above explains that most patients who have taken the Placebo drug are with the stage one to stage four, however the patients who are stage 3 and less have taken the D-penicillamine. 
---
## Visual Two:
![image](https://user-images.githubusercontent.com/122195358/231598307-3d44ff70-a644-447f-96f1-55a19d34e781.png)
#### The visual above depicts that patients with a low bilirubin have taken the D-penicillamine and the patints with high biliburin have taken the placebo which indicates whether the drug was affected or not. 
---
## Conclusion: 
Using the random forest classifier was the best method because it had a 64% accuracy while the KNN model had a 62% accuracy. 
